Accelerated hematopoietic recovery with angiotensin-(1-7) after total body radiation

International Journal of Radiation Biology

Volumn 88, Issue 6, 2012, Pages 466-476

  Rodgers, Kathleen E ^a   Espinoza, Theresa ^a   Roda, Norma ^a   Meeks, Christopher J ^a   Hill, Colin ^b   Louie, Stan G ^a   Dizerega, Gere S ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Angiotensin; Hematopoiesis; Progenitor cells; Radiation; TBI

Indexed keywords

ANGIOTENSIN[1-7]; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLEEDING TIME; BLOOD; BONE MARROW CELL; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROID CELL; GAMMA RADIATION; HEALTH CARE SYSTEM; LEUKOPENIA; MEGAKARYOCYTE; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; STEM CELL; SURVIVAL; THROMBOCYTOPENIA; WHOLE BODY RADIATION;

ANEMIA; ANGIOTENSIN I; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; LEUKOPENIA; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; RADIATION-PROTECTIVE AGENTS; RENIN-ANGIOTENSIN SYSTEM; THROMBOCYTOPENIA; WHOLE-BODY IRRADIATION;

ANIMALIA; MUS;

EID: 84861858870     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2012.676228     Document Type: Article

References (38)

1. Azizi M, Rousseau A, Ezan E, Guyene TT, Michelet S, Grognet JM, Lenfant M, Corvol P, Menard J. 1996. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. Journal of Clinical Investigation 97:839-844.
2. Barshishat-Kupper M, Mungunsukh O, Tipton AJ, McCart EA, Panganiban RA, Davis TA, Landauer MR, Day RM. 2011. Captopril modulates hypoxia- inducible factors and erythropoietin responses in a murine model of total body irradiation. Experimental Hematology. 39:293-304.
3. Brown AP, Chung EJ, Urick ME, Shield WP 3rd, Sowers AL, Thetford A, Shankavaram UT, Mitchell JB, Citrin DE. 2010. Evaluation of the fullerene compound DF-1 as a radiation protector. Radiation Oncology 5:34.
4. Charrier S, Michaud A, Badaoui S, Giroux S, Ezan E, Sainteny F, Corvol P, Vainchenker W. 2004. Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells. Blood 104:978-985.
5. Chisi JE, Briscoe CV, Ezan E, Genet R, Riches AC, Wdzieczak-Bakala J. 2000. Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no Effect on myeloid leukaemia cell proliferation. British Journal of Haematology 109:563-570.
6. Chisi JE, Wdzieczak-Bakala J, Thierry J, Briscoe CV, Riches AC. 1999. Captopril inhibits the proliferation of hematopoietic stem and progenitor cells in murine long-term bone marrow cultures. Stem Cells 17:339-344.
7. Davis TA, Landauer MR, Mog SR, Barshishat-Kupper M, Zins SR, Amare MF, Day RM. 2010. Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation. Experimental Hematology 38:270-281.
8. Day RM, Barshishat-Kupper M, Mog SR, McCart EA, Prasanna PG, Davis TA, Landauer MR. 2008. Genistein protects against biomarkers of delayed lung sequelae in mice surviving high-dose total body irradiation. Journal of Radiation Research (Tokyo) 49:361-372.
9. Dicarlo AL, Poncz M, Cassatt DR, Shah JR, Czarniecki CW, Maidment BW. 2011. Medical countermeasures for platelet regeneration after radiation exposure. Radiation Research 176:134-137.
10. Ellefson DD, diZerega GS, Espinoza T, Roda N, Maldonado S, Rodgers KE. 2004. Synergistic Effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice. Cancer Chemotherapy Pharmacology 53:15-24.
11. Guinan EC, Barbon CM, Kalish LA, Parmar K, Kutok J, Mancuso CJ, Stoler-Barak L, Suter LA, Russel JD, Palmer CD, Gallington LC, Voskertchian A, Vergilio J-A, Cole G, Zhu K, D'Andrea A, Soiffer R, Weiss JP, Levy O. 2011. Bactericidal/Permeability-Increasing Protein (rBPI21) and fl uoroquinolone mitigate radiation-induced bone marrow aplasia and death. Science Translational Medicine 3: 111-118.
12. Haznedaroglu IC, Ozturk MA. 2003. Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. International Journal of Biochemistry and Cell Biology 35: 867-880.
13. Heringer-Walther S, Eckert K, Schumacher SM, Uharek L, Wulf-Goldenberg A, Gembardt F, Fichtner I, Schultheiss HP, Rodgers K, Walther T. 2009. Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo. Haematologica 94:857-860.
14. Hosseinimehr SJ. 2007. Trends in the development of radioprotective agents. Drug Discovery Today 12:794-805.
15. Iyer SN, Ferrario CM, Chappell MC. 1998. Angiotensin-(1-7) contributes to the antihypertensive Effects of blockade of the reninangiotensin system. Hypertension 31:356-361.
16. Jackson CW. 1973. Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood 42:413-421.
17. Jokubaitis VJ, Sinka L, Driessen R, Whitty G, Haylock DN, Bertoncello I, Smith I, Peault B, Tavian M, Simmons PJ. 2008. Angiotensin converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal and adult hematopoietic tissues. Blood 111: 4055-4063.
18. Landauer MR, Srinivasan V, Seed TM. 2003. Genistein treatment protects mice from ionizing radiation injury. Journal of Applied Toxicology 23:379-385.
19. Molteni A, Moulder JE, Cohen EF, Ward WF, Fish BL, Taylor JM, Wolfe LF, Brizio-Molteni L, Veno P. 2000. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin type II type 1 receptor blocker. International Journal of Radiation Biology 76:523-532.
20. Mrug M, Stopka T, Julian BA, Prchal JF, Prchal JT. 1997. Angiotensin II stimulates proliferation of normal early erythroid progenitors. Journal of Clinical Investigation 100:2310-2314.
21. Peng R, Li Y, Brezner K, Litherland S, Clare-Salzler MJ. 2003. Abnormal peripheral blood dendritic cell populations in type 1 diabetes. Annals of New York Academy of Sciences 1005:222-225.
22. Richmond RS, Tallant EA, Gallagher PE, Ferrario CM, Strawn WB. 2004. Angiotensin II stimulates arachidonic acid release from bone marrow stromal cells. Journal of Renin Angiotensin Aldosterone System 5:176-182.
23. Rodgers K, Xiong S, DiZerega GS. 2003. Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy. Cancer Chemotherapy and Pharmacology 51: 97-106.
24. Rodgers K, Xiong S, Felix J, Roda N, Espinoza T, Maldonado S, Dizerega G. 2001. Development of angiotensin (1-7) as an agent to accelerate dermal repair. Wound Repair Regeneration 9:238-247.
25. Rodgers KE, Oliver J, diZerega GS. 2006. Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer. Cancer Chemotherapy Pharmacology 57:559-568.
26. Rodgers KE, Xiong S, diZerega GS. 2002. Accelerated recovery from irradiation injury by angiotensin peptides. Cancer Chemotherapy Pharmacology 49:403-411.
27. Rodgers KE, Xiong S, Steer R, diZerega GS. 2000. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 18: 287-294.
28. Roks AJ, Rodgers K, Walther T. 2011. Effects of renin angiotensin system on vasculogenesis-related progenitor cells. Current Opinion in Pharmacology 11:162-174.
29. Rousseau-Plasse A, Wdzieczak-Bakala J, Lenfant M, Ezan E, Genet R, Robinson S, Briscoe T, Melville J, Riches A. 1998. Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo. Experimental Hematology 26:1074-1079.
30. Shen XZ, Bernstein KE. 2011. The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis. Cell Cycle 10:1363-1369.
31. Slukvin II. 2009. Renin angiotensin system and hemangioblast development from human embryonic stem cells. Expert Review in Hematology 2:137-143.
32. Strawn WB, Richmond RS, Ann Tallant E, Gallagher PE, Ferrario CM. 2004. Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. British Journal of Haematology 126:120-126.
33. Tavian M, Biasch K, Sinka L, Vallet J, Peault B. 2010. Embryonic origin of human hematopoiesis. International Journal of Developmental Biology 54:1061-1065.
34. Wang Y, Qian C, Roks AJ, Westermann D, Schumacher SM, Escher F, Schoemaker RG, Reudelhuber TL, van Gilst WH, Schultheiss HP, Tschope C, Walther T. 2010. Circulating rather than cardiac angiotensin-( 1-7) stimulates cardioprotection after myocardial infarction. Circulation Heart Failure 3:286-293.
35. Ward WF, Kim, YT, Molteni A, Solliday NH. 1988. Radiation-induced pulmonary endothelial dysfunction in rats: Modifi cation by an inhibitor of angiotensin converting enzyme. International Journal of Radiation Oncology, Biology and Physiology 15:135-140.
36. Ward WF, Molteni A, Kim YT, Ts'ao C. 1989. Structure-function analysis of angiotensin-converting enzyme inhibitors as modifi ers of radiation- induced pulmonary endothelial dysfunction in rats. British Journal of Radiation 62:348-354.
37. Wei L, Alhenc-Gelas F, Corvol P, Clauser E. 1991. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. Journal of Biological Chemistry 266:9002-9008.
38. Zambidis ET, Park TS, Yu W, Tam A, Levine M, Yuan X, Pryzhkova M, Peault B. 2008. Expression of angiotensin-converting enzyme (CD143) identifi es and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 112:3601-3614.